We are developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
We have conducted more than 50 clinical trials as we strive to bring important new medicines to patients with diseases like ALS, heart failure, HCM and SMA.
Cytokinetics' financial calendar corresponds with the annual calendar and earnings announcements are typically made the last week of the month following the end of each quarter.
How do I get a copy of Cytokinetics' financial statements, such as Form 10-Q, Form 10-K, Form 8-K or the Annual Report, when available?
Our Form 10-Qs, Form 10-Ks, Form 8-Ks and other reports, when available, are listed on the SEC's web site, www.sec.gov, please search on "Cytokinetics" or visit the Investor Center's SEC links within this website to visit the SEC's web site.
If I have questions regarding the Company, how do I contact Cytokinetics' Investor Relations?
Please contact:
Investor Relations
Cytokinetics, Inc.
280 East Grand Avenue
South San Francisco, CA 94080
Phone: 650-624-3060
Fax: 650-624-3070
Email: investor@cytokinetics.com